Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • Johns Hopkins Medicine Receives $200M To Lead Consortium To Combat Tuberculosis

    The Baltimore Sun (8/4, Cohn) reports, “Johns Hopkins Medicine has received $200 million in federal funding to head up a consortium aimed at treating and stemming spread of one of the world’s oldest and deadliest scourges: tuberculosis.” The funding “from...
    Full Article
  • Lymphocyte Subset Panels (AKA T4T8 Assays)

    Abstract Not Available
    Full Article
  • Monkeypox in 2022: A New Outbreak of an Old Disease

    Abstract Not Available
    Full Article
  • Nearly 20M Doses Of Monkeypox Vaccine Reportedly Expired In US Before Outbreak

    The New York Times (8/1, Goldstein) reports that “less than a decade ago, the United States had some 20 million doses of” the Jynneos vaccine for smallpox and monkeypox in the Strategic National Stockpile. However, the supply “had only some 2,400 usable d...
    Full Article
  • Polio Present In Wastewater In New York City One Month Before Confirmed Case, Health Officials Say

    Reuters (8/1) reports, “The polio virus was present in wastewater in a New York City suburb a month before health officials there announced a confirmed case of the disease last month, state health officials said on Monday, urging residents to be sure they...
    Full Article
  • CDC Adds Three Destinations To “High” Risk Travel Category For COVID-19

    CNN (8/1, Brown, Hunter) reports the US CDC “on Monday added three destinations to its ‘high’ risk category for travel” for COVID-19 – Romania, Moldova, and St. Pierre and Miquelon. There were nearly “125 destinations at Level 3 on August 1,” and such “lo...
    Full Article
  • Monthly Treatment With Subcutaneous Casirivimab/Imdevimab Well Tolerated, Tied To Protection Against COVID-19, Trial Shows

    Infectious Disease Advisor (8/1, Mermelstein) reports, “Monthly treatment with subcutaneous casirivimab/imdevimab [REGEN‑COV] was well tolerated and associated with significant protection against COVID-19 infection, according to results of a phase 1, doub...
    Full Article
  • Study Identifies Slight Increase In Rate Of HIV Virologic Suppression During COVID-19 Pandemic Among Some Patients In Malawi

    Infectious Disease Advisor (8/1, Nye) reports, “Despite interruptions in health care during the COVID-19 pandemic, there was a slight increase in the rate [of] HIV virologic suppression during the pandemic among some patients in Malawi,” according to a “p...
    Full Article
  • Updated Recommendation Exempts Solid Organ Transplant Candidates Aged Younger Than 12 Years From Testing For HIV, Hepatitis B And Hepatitis C Viruses

    Healio (8/1, Burba) reports, “The U.S. Public Health Service has published an updated recommendation for solid organ transplant candidates aged younger than 12 years” in the CDC’s Morbidity and Mortality Weekly Report. The updated recommendation “now exem...
    Full Article
  • Federation Of American Hospitals Urges HHS To Extend COVID-19 Public Health Emergency Into 2023

    RevCycle Intelligence (8/1, Bailey) reports, “The Federation of American Hospitals (FAH) has urged HHS to extend the COVID-19 public health emergency (PHE) into 2023, stressing that hospitals across the country still rely on the accompanying regulatory wa...
    Full Article
  • Biden Administration Preparing To Launch Updated COVID-19 Booster Campaign In September

    The Washington Post (7/29, McGinley, Diamond) reported, “The Biden administration is preparing to launch a coronavirus booster campaign in September – weeks earlier than expected – with a new, reformulated vaccine designed to provide stronger protection a...
    Full Article
  • US Facing Shortfall Of Monkeypox Vaccine Doses Amid Rising Cases

    The Washington Post (7/30, Diamond) reported that while federal officials “touted the arrival of hundreds of thousands of additional monkeypox vaccine doses,” the US “is entering a critical three-month period where cases may continue to multiply, but no m...
    Full Article
  • Twenty-Three Infants Admitted To Tennessee Hospital For Treatment Of Parechovirus, CDC Report Says

    The New York Times (7/29, Traub) said that “from April 12 to May 24” of this year, “23 children were admitted to a Tennessee hospital for treatment of parechovirus,” according to a CDC report. Of the children, 21 “have recovered without complications, but...
    Full Article
  • Scientists Working To Better Understand Monkeypox To Combat Outbreak

    The New York Times (7/29, Mandavilli) reported monkeypox “has bloomed into a global threat, infecting more than 20,000 people in 75 countries and forcing the World Health Organization to declare a worldwide health emergency.” Despite being known, “the vir...
    Full Article
  • US, Canada Formally Announce Support Of Undetectable = Untransmittable Campaign

    Healio (7/30, Stulpin) reported, “The United States and Canada have formally announced their support of the Undetectable = Untransmittable, or U=U, campaign,” that was launched by the Prevention Access Campaign “in 2016 to communicate the consensus that p...
    Full Article
  • US Reports Most Monkeypox Cases In Global Outbreak, Data Reveal

    The Wall Street Journal (7/26, Kamp, Subscription Publication) reports that according to federal data, the US has reported over 3,400 confirmed or suspected cases of monkeypox, making the US the country with the most known infections amid the global outbr...
    Full Article
  • Omicron Subvariant BA.5 Makes Up About 82% Of Variants In US, CDC Estimates

    Reuters (7/26, Leo) reports, “The BA.5 subvariant of Omicron was estimated to make up 81.9% of the circulating coronavirus variants in the United States for the week ended July 23, the U.S. Centers for Disease Control and Prevention (CDC) said on Tuesday....
    Full Article
  • Patients Who Report Smoking Or Vaping Prior To COVID-19 Hospitalization More Likely To Experience Severe Complications, Study Finds

    The Hill (7/26, Barnes) reports, “Patients who reported smoking or vaping prior to COVID-19 hospitalization were more likely to experience severe complications, including death, than nonsmokers, according to a... study” published in PLOS One. Moreover, “s...
    Full Article
  • Rebound Cases Following Paxlovid Treatment Appear Rare

    NBC News (7/26, Bendix) reports on the characteristics of rebound cases following COVID-19 treatment with Paxlovid, adding that “a small minority of people who take Paxlovid see a...rebound effect.” Rates of rebound cases “are around 5% among the tens of...
    Full Article
  • Rate Of Severe Clostridioides Difficile Infections Rose During Second Wave Of COVID-19 Pandemic, Study Finds

    Infectious Disease Advisor (7/26, Mermelstein) reports, “There was an increase in the rate of severe Clostridioides difficile infections (CDI) during the second wave of the COVID-19 pandemic, potentially due to delays in diagnostic testing and restriction...
    Full Article
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id